In Vitro Antimicrobial, Antibiofilm and Hemolytic Activity of Nisin Against Staphylococcus aureus Isolates from Bovine Mastitis: a Brief Report

In the world of dairy farming, the health of a cow's udder is the foundation of milk production. When bacteria invade this sensitive tissue, they cause a painful and costly condition known as mastitis. Among the many bacteria that can cause this infection, Staphylococcus aureus is a particularly stubborn foe. This microbe is notorious for two reasons: it has learned to resist many common medicines, and it builds a protective shield around itself called a biofilm. This biofilm acts like a fortress, allowing the bacteria to hide from treatments and persist in the cow's body, often leading to chronic illness and reduced milk quality. For decades, farmers have relied on antibiotics to fight these infections, but the rising tide of resistance has made these drugs less effective, creating an urgent need for new ways to protect both animal health and the dairy industry.

Scientists are now looking to nature for solutions, specifically at a substance called nisin. Nisin is a natural peptide, a small chain of amino acids produced by certain bacteria that acts as a weapon against other bacteria. It has long been known to be safe for use in food, but researchers wanted to know if it could also serve as a powerful tool against the specific strains of S. aureus that plague dairy cows. A team of researchers from Brazil set out to test this idea in a laboratory setting. They gathered twenty-five different samples of the bacteria, taken from cows suffering from mastitis, to see if nisin could stop them from growing, break down their protective biofilms, and do so without harming the cow's own blood cells.

The researchers began by checking how resistant these bacterial samples were to standard antibiotics. The results confirmed a troubling trend: the bacteria were highly resistant to the most common class of drugs used to treat them, known as beta-lactams. None of the samples responded to penicillin, ampicillin, or oxacillin. However, the bacteria were still vulnerable to other types of antibiotics, such as gentamicin and certain fluoroquinolones. This confirmed that while some traditional drugs still work, the bacteria are becoming increasingly difficult to treat with the usual options, highlighting the need for alternative approaches.

Next, the team tested the power of nisin against these resistant bacteria. They found that nisin was effective at stopping the growth of every single sample they tested. To measure this, they determined the lowest amount of nisin needed to halt the bacteria's multiplication, a value known as the minimum inhibitory concentration. For most of the bacteria, this amount was quite low, meaning a small dose was enough to stop them. Even more importantly, they found that nisin did not just stop the bacteria from growing; it actually killed them. In the laboratory, the amount of nisin required to kill the bacteria was only slightly higher than the amount needed to stop them from growing, indicating that the substance is a potent killer of these specific germs.

The study then turned its attention to the biofilms, the protective shields that make these infections so hard to cure. The researchers found that eighty percent of the bacterial samples were capable of forming these biofilms, with some producing them very strongly. When they added nisin to the mix before the biofilms could form, the substance dramatically reduced the amount of slime the bacteria produced. It was highly effective at preventing the fortress from being built in the first place. When they tried to use nisin to destroy biofilms that had already formed, the results were more modest. The substance was able to partially break down some of the existing structures, but it did not completely wipe them out. This suggests that nisin is best used as a preventative measure or an early intervention, stopping the infection before the bacteria can build their defenses.

Finally, the researchers had to ensure that this new treatment would not harm the cows themselves. They tested whether nisin would damage red blood cells, a process called hemolysis, which would indicate toxicity. The results showed that nisin is safe at the concentrations needed to kill the bacteria. At the levels required to stop and kill the S. aureus, the substance caused almost no damage to the blood cells. It was only when the concentration was raised significantly higher that the blood cells began to break down. This creates a safe window where the medicine can fight the infection without hurting the animal.

The findings of this study suggest that nisin holds significant promise as a new tool for managing mastitis in dairy cattle. It offers a way to fight bacteria that have become resistant to traditional antibiotics and can prevent the formation of the protective biofilms that make infections chronic. While it may not be able to completely dissolve a fully established biofilm, its ability to kill the bacteria and stop them from building defenses in the early stages of infection makes it a strong candidate for future treatments. By offering a safe and effective alternative, nisin could help farmers control this widespread disease, protecting animal welfare and ensuring the quality of milk production.